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A B S T R A C T 
The tracheal tone is influenced by histaminergic receptors and by the epithelium derived relaxing factor 
(EpDRF) which contains metabolites of arachidonic acid. The aims of the present study were the following: 1) 
to investigate the role of Hi- and Нз-receptors in the tracheal tone regulation using as test substances hista­
mine (H), the Hi-receptor antagonist mepyramine and the Нз-receptor agonist (R)a-methylhistamine [(R)a 
-MHA]; 2) to study the influence of the cyclooxygenase (COX) inhibitor indomethacin on the tracheal respon­
siveness to the examined substances. The experiments were carried out on isolated guinea-pig tracheal rings. 
Histamine at cumulative concentrations contracts the trachea. In the presence of mepyramine the concentra­
tion-response curves to H are shifted to the right that proves the concept of the Hi-receptor mediated tracheal 
contraction. In the presence of indomethacin the concentration-response curves to H are shifted to the left and 
the maximal contraction is significantly increased due to the inhibition of the C O X pathway. (R)oc-MHA at 
concentrations up to lxlfH M leads to a slight tracheal contraction, which is probably Hi-receptor mediated as 
it is reduced in the presence of mepyramine. The ЗхКИ M concentration of (R )a-MHA relaxes the trachea 
probably due to its Нз-receptor agonistic activity. In the presence of indomethacin this relaxation is turned to 
a further contraction. After tracheal precontraction by H, (R ) a -MHA concentration dependently relaxes the 
trachea. This spasmolytic effect is insignificantly influenced by mepyramine and is almost completely abol­
ished in the presence of indomethacin, which shows that it is probably due to an increased production of me­
tabolites of arachidonic acid. 
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I N T R O D U C T I O N 
The histaminergic Hi- and Нз-receptors as well as the epi­
thelium derived relaxing factor (EpDRF) take part in the 
tracheal tone modulation. The EpDRF contains metabolites 
of arachidonic acid, in particular prostaglandins Ei and E2 
(PGE1 and PGE2), and nonprostanoid substances as well 
(4,5,6,8). The histamine-induced bronchoconstriction is 
due to the stimulation of Hi-receptors. Mepyramine is an 
Hi-receptor antagonist, while (R)a-methylhistamine 
[(R)a-MHA] is а potent and selective Нз-receptor agonist 
and possesses only 1% of the activity of histamine on Hi-
and Hi-receptors (3). 
Indomethacin, a non-selective cyclooxygenase (COX) in­
hibitor, leads to an airway hyperresponsiveness in vitro as a 
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result of the decreased synthesis of the inhibitory 
prostanoids (PGE2 and PGI I ) . These prostanoids are nor­
mally synthesized by the bronchial epithelium and inhibit 
the bronchial contraction by LTC4 and LTD4 (1,2). 
The aims of the present study were: 
1. To study the role of Hi- and Нз-receptors in the 
regulation of guinea-pig tracheal tone in vitro using as 
test substances histamine, mepyramine and 
(R)a-MHA. 
2. To investigate the influence of indomethacin on the 
tracheal responsiveness to Hi - and Нз-receptor agonists. 
M A T E R I A L AND M E T H O D S 
Rings, two adjacent cartilages wide, were isolated from 
male guinea pigs (450-600g) and tied to force-displacement 
transducers for the measurement of isometric tension re­
sponses. 
They were placed in organ baths (37°C) containing a solu­
tion with the following composition (millimolar): NaCl 
119, KC1 4.6, CaCb 1.5, MgCb 1.2, NaHC0 3 15, 
NaH2P041.2 and glucose 11. The solution was gassed with 
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95% O2 and 5% CO2 for maintenance of pH 7,4. Before 
each experiment the tissues were equilibrated for 60min un­
der a resting load of 2g and washed every 15min with fresh 
solution. The number of organs (taken from different ani­
mals) was six in all the experiments. The drugs used were 
the following: histamine dihydrochloride (Fluka Chemie, 
Switzerland), mepyramine (Sigma Chemical Co, USA), 
(R)a-MHA (Free University, Berlin, Germany) and 
indomethacin (Fluka Chemie, Switzerland). 
Calculation of organ responses 
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Fig. I A. Effect of histamine alone and in the presense of 
mepyramine on guinea-pig trachea 
The experiments included: 
1. Registration of tissue isometric tension responses to 
cumulative concentrations of histamine (from lxK>7M 
to 3x1 (HM) alone and in the presence of three 
concentrations of mepyramine (lxl0" 8M, IxKFM and 
IxKHM). 
2. Registration of tissue responses to the same cumulative 
concentrations of histamine after 20min. equilibration 
of the organs in the presence of indomethacin 
(lxl0- 5M). 
3. Registration of organ responses to cumulative 
concentations of (R)a-MHA (from 1 х107М to ЗхКНМ) 
alone and in the presence of two concentrations of 
mepyramine (lxl0-"M and lxlO^'M). 
4. Registration of the responses to the same cumulative 
concentrations of (R)a-MHA after 20min. equilibration 
of the organs in the presence of indomethacin 
(lxl0- 5M). 
5. Precontraction of the trachea by histamine (З.хЮ^М) 
and registration of the organ responses to cumulative 
concentrations of (R)a-MHA (from lxlO"7M to IxlO'M) 
applied alone and in the presence of mepyramine 
( lx l (FM) . 
6. Precontraction of the trachea by histamine (3x 10 4М) in 
the presence of indomethacin ( lxKFM) and registration 
of the responses to cumulative concentrations of 
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Fig. IB. Responses of guinea-pig trachea to cumulative 
concentrations of histamine alone and in the presence of 
lxlff M of indomethacin, n = 6 in all the experiments 
100% contraction. The tissue responses to each concentra­
tion of the examined substances were calculated as a per­
centage of the maximal contraction. The relaxation was cal­
culated as a percentage of histamine precontraction. 
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Fig. 2A. Responses of guinea-pig trachea to cumulative 
concentrations of (R)-MHA alone and in the presence of 
1x10'M and lxlff6 M of mepyramine, n = 6 in all the 
experiments 
Statistical analysis 
Results are given as mean ± SEM. Differences between 
means were considered significant at p<0,05. The IC50 (the 
concentration causing 50% inhibition of the maximal tra-
'.2 
Participation of H r and H3-receptors in the regulation 
cheal contraction) of mepyramine was determined by the 
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Fig. 2B. Responses of guinea-pig trachea to cumulative 
concentrations of (R)a-MHA alone and in the presence 
of lxlCF3M of indomethacin. n = 6 in all the experiments 
R E S U L T S AND D I S C U S S I O N 
Experiments with histamine 
Histamine at cumulative concentrations from l x K F M to 
3xl0 4 M leads to a concentration-dependent contraction of 
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Fig. ЗА. Responses of guinea-pig trachea precontracted 
by histamine (3xl(J M) to cumulative concentrations of 
(Rja-MHA alone and in the presence of 1x10' M of 
mepyramine, n = 6 in all the experiments 
In the presence of mepyramine ( l x l 0 8 M . Ixl0- 7M and 
lxKK'M) the concentration-response curves to histamine 
are dose-dependently shifted to the right (Fig. 1 A); pDi for 
mepyramine is 7,02±0,89. In the presence of indomethacin 
( I xl0"5M) the dose-dependent curve to histamine is shifted 
to the left and the maximal contraction is increased up to 
152,7±12,4% (Fig. IB) ; pD: for histamine in this case is 
5.78±0,4. 
Experiments with (R)a-MK4 
(R)a-MHA (from l.xKFM to IxlCHM) leads to a slight 
dose-dependent contraction of guinea-pig tracheal smooth 
muscle (Emax=l4,22±2,58%) while the 3xl0-»M concentra­
tion of (R)a-MHA relaxes the trachea (E =-19,28±3,06%) 
(Fig. 2A). 
The presence of IxlO'M mepyramine leads to an insignifi­
cant reduction of the contractile responses to (R)a-MHA. 
In the presence of IxlO^M mepyramine the contractile re­
sponse to lx 10'M (R)a-MHA is significantly (p < 0,05) re­
duced (Emax =6,1 ±2,27%) (Fig. 2A). Mepyramine at both 
concentrations does not influence the relaxing effect of the 
3xl0-*M concentration of (R)a-MHA (Fig. 2A). 
In the presence of indomethacin (1 xl0"5M) the responses to 
(R)a-MHA from lxl0' 7M to IxKHM are insignificantly 
changed while the ЗхЮ^М concentration of (R)a-MHA 
does not relax but further contracts the trachea 
(E=14,44±5,67%)(Fig.2B). 
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Fig. 3B. Responses of guinea-pig trachea pre­
contracted by histamine (Зх/О'^М) in the presence of 
indomethacin (IxlO'M) to cumulative concentrations 
of (R)a-MHA, n=6 in all the experiments 
After precontraction of the trachea by 3x 1 O^M of histamine 
(R)a-MHA (from lxlO"7M to lxlO"3M) leads to a concen­
tration-dependent relaxation of the tracheal rings and the 
tracheal tone is almost turned to the pretreatment base level; 
pD 2 for (R)a-MHA is 3,29±0,048 (Fig. ЗА). 
The spasmolytic effect of (R)a-MHA on the trachea 
precontracted by histamine is not significantly changed in 
the presence lxlO"7M concentration of mepyramine (Fig. 
ЗА). (R)a-Ml IA produces а slight concentration-dependnt 
relaxation of the tracheal rings precontracted by histamine 
in the presence of indomethacin. The relaxant effect of 
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ЗхЮ^М (R)a-MHA in this case is 10,97 ±7,02% while the 
relaxant effect of the same concentration of (R)a-MHA in 
the absence of indomethacin is 46,39 ±4,88% (Fig. 3B). 
C O N C L U S I O N S 
1. The tracheal contraction by histamine is a result of its 
agonistic action on the Hi- receptors, which are coupled to 
inositol phosphate hydrolysis (6). The concept of the Hi- re­
ceptor-mediated tracheal contraction is supported by the 
mepyramine-induced rightward shift of the concentra­
tion-response curves to histamine. Tracheal responsiveness 
to histamine is increased in the presence of the COX inhibi­
tor indomethacin. This may be a result of the actions of 
LTC4 and LTD4 the effects of which are normally antago­
nized by the inhibitory prostaglandins (PGE2 and PGI1) 
synthesized in the COX pathway (1,2). 
2. The contractile effect of the lower concentrations of 
(R)a-MHA might be due to an Hi- receptor agonistic activ­
ity as it is reduced in the presence of mepyramine. 
3. The relaxant effect of the ЗхЮ^М concentration of 
(R)a-MHA applied alone as well as the relaxation of hista-
mine-precontracted guinea-pig trachea exerted through cu­
mulative (R)a-MHA concentrations is, probably, due to its 
agonistic action on the Нз-receptors. 
Several mechanisms may be involved in this tracheal relax­
ation. There is evidence that Нз-receptor stimulation inhib­
its vagal cholinergic transmission in the airways and 
non-adrenergic non-cholinergic bronchoconstriction as 
well (5). Нз-receptor stimulation also mediates the relax­
ation of guinea-pig trachea by increasing the release of 
EpDRF containing metabolites of arachidonic acid as this 
relaxation is abolished in the presence of the COX inhibitor 
indomethacin (4,7.8). 
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